Laurus Labs (BOM:540222) Interest Expense : ₹-1,829 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Laurus Labs's interest expense for the three months ended in Mar. 2024 was ₹ -505 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-1,829 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Laurus Labs's Operating Income for the three months ended in Mar. 2024 was ₹ 1,392 Mil. Laurus Labs's Interest Expense for the three months ended in Mar. 2024 was ₹ -505 Mil. Laurus Labs's Interest Coverage for the quarter that ended in Mar. 2024 was 2.76. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Laurus Labs Interest Expense Historical Data

The historical data trend for Laurus Labs's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs Interest Expense Chart

Laurus Labs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-733.90

-552.80

-757.60

-1,651.70

-1,829.00

Laurus Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-531.00	-391.90	-423.90	-508.20	-505.00

Laurus Labs Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-1,829 Mil.

Laurus Labs (BOM:540222) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Laurus Labs's Interest Expense for the three months ended in Mar. 2024 was ₹-505 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₹1,392 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₹8,604 Mil.

Laurus Labs's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	1392.4	/	-505
	=	2.76

The higher the ratio, the stronger the company's financial strength is.

Laurus Labs (BOM:540222) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Interest Expense

Traded in Other Exchanges

LAURUSLABS:India

Address

Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034

Website

https://www.lauruslabs.com

Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs (BOM:540222) Headlines

No Headlines